Cogent Life Science (US) is a global company focused on the development, manufacturing, marketing and distribution of Gene therapy building blocks, Active pharmaceutical ingredients (“API”) and Key starting materials (“KSM”) using advanced CFR technology.

Cogent Life Science operates three Contract manufacturing facilities in India and supplies the world’s top pharmaceutical companies with high-quality products. Cogent Life Science is currently building a fourth, state-of-the-art manufacturing unit close to Mumbai in response to the ever-increasing demand for API and the global API shortage due to COVID-19.

Cogent group of Companies can also enter into Contract Development and Manufacturing Organization (CDMO) to provide integrated service offerings to meet the demands of end-to -end discovery and development services on a single platform to deliver multimodal solutions.

We have an international team with around 250 years of combined experience in Research, Product Development and Commercialization. This team has several patents and have worked at various capacities across the world.